CeNeRx BioPharma's Death

CeNeRx BioPharma raised a round of funding on June 20, 2013. Investors include Dead.

CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clin…

Articles about CeNeRx BioPharma's Death: